LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

STERIS PLC

Cerrado

SectorSalud

243.67 0.19

Resumen

Variación precio

24h

Actual

Mínimo

242.22

Máximo

243.68

Métricas clave

By Trading Economics

Ingresos

-27M

146M

Ventas

110M

1.5B

P/B

Media del Sector

39.363

51.198

BPA

2.74

Rentabilidad por dividendo

0.94

Margen de beneficio

9.892

Empleados

17,787

EBITDA

-158M

216M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+9.07% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.94%

2.40%

Próximas Ganancias

5 ago 2025

Fecha Próximo Dividendo

26 jun 2025

Próxima Fecha de Ex Dividendo

10 jun 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

912M

24B

Apertura anterior

243.48

Cierre anterior

243.67

Noticias sobre sentimiento de mercado

By Acuity

36%

64%

112 / 380 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

STERIS PLC Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

14 may 2025, 20:30 UTC

Ganancias

Steris Sees FY Adj EPS $9.90-Adj EPS $10.15 >STE

14 may 2025, 20:30 UTC

Ganancias

Steris 4Q Rev $1.5B >STE

14 may 2025, 20:30 UTC

Ganancias

Steris 4Q Adj EPS $2.74 >STE

5 feb 2025, 21:35 UTC

Ganancias

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5 feb 2025, 21:34 UTC

Ganancias

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5 feb 2025, 21:34 UTC

Ganancias

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5 feb 2025, 21:33 UTC

Ganancias

Steris 3Q EPS $1.75 >STE

5 feb 2025, 21:30 UTC

Ganancias

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5 feb 2025, 21:30 UTC

Ganancias

Steris 3Q Rev $1.4B >STE

5 feb 2025, 21:30 UTC

Ganancias

Steris 3Q Adj EPS $2.32 >STE

6 nov 2024, 21:41 UTC

Ganancias

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6 nov 2024, 21:40 UTC

Ganancias

Steris 2Q EPS $1.51 >STE

6 nov 2024, 21:30 UTC

Ganancias

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6 nov 2024, 21:30 UTC

Ganancias

Steris 2Q Adj EPS $2.14 >STE

6 nov 2024, 21:30 UTC

Ganancias

Steris 2Q Rev $1.3B >STE

6 ago 2024, 20:36 UTC

Ganancias

Steris 1Q Adj EPS $2.03 >STE

6 ago 2024, 20:30 UTC

Ganancias

Steris 1Q Net $139.9M >STE

6 ago 2024, 20:30 UTC

Ganancias

Steris 1Q EPS $1.41 >STE

6 ago 2024, 20:30 UTC

Ganancias

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

Comparación entre iguales

Cambio de precio

STERIS PLC Esperado

Precio Objetivo

By TipRanks

9.07% repunte

Estimación a 12 meses

Media 265.83 USD  9.07%

Máximo 280 USD

Mínimo 250 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para STERIS PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

4

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

225 / 226.35Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

112 / 380 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.